Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke S Howard

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Nature Communications|January 6, 2024
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertensionAnna Ulrich, Yukyee Wu, Harmen Draisma, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 24, 2023
Long-term effects of pulmonary endarterectomy on pulmonary hemodynamics, cardiac function, and exercise capacity in chronic thromboembolic pulmonary hypertensionAzar Kianzad, Andrea Baccelli, Natalia J Braams, et al.
Advances in Therapy|August 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension StudyOlivier Sitbon, Sandeep Sahay, Pilar Escribano Subías, et al.
The Lancet. Respiratory Medicine|May 5, 2024
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trialRobert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, et al.
American Journal of Respiratory and Critical Care Medicine|August 11, 2025
Inflammation and Obesity Correlate in Pulmonary Hypertension but Associate with Diverging OutcomesEckart De Bie, Priscilla Correa-Jaque, Rowena Jones, et al.
The European Respiratory Journal|January 19, 2019
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertensionMichael Newnham, Kieron South, Marta Bleda, et al.
Respiration; International Review of Thoracic Diseases|June 12, 2026
Real-world Sotatercept Eligibility: Analysis from the FOCUS-PAH RegistryGiulio Savonitto, Giovanni Santi, Matteo Pagnesi, et al.
The European Respiratory Journal|December 23, 2018
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertensionEkkehard Grünig, Christina Eichstaedt, Joan-Albert Barberà, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2020
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J Rhodes, Pablo Otero-Núñez, John Wharton, et al.
ERJ Open Research|February 23, 2023
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19Luke Daines, Bang Zheng, Omer Elneima, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Nature Communications|January 6, 2024
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertensionAnna Ulrich, Yukyee Wu, Harmen Draisma, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 24, 2023
Long-term effects of pulmonary endarterectomy on pulmonary hemodynamics, cardiac function, and exercise capacity in chronic thromboembolic pulmonary hypertensionAzar Kianzad, Andrea Baccelli, Natalia J Braams, et al.
Advances in Therapy|August 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension StudyOlivier Sitbon, Sandeep Sahay, Pilar Escribano Subías, et al.
The Lancet. Respiratory Medicine|May 5, 2024
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trialRobert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, et al.
American Journal of Respiratory and Critical Care Medicine|August 11, 2025
Inflammation and Obesity Correlate in Pulmonary Hypertension but Associate with Diverging OutcomesEckart De Bie, Priscilla Correa-Jaque, Rowena Jones, et al.
The European Respiratory Journal|January 19, 2019
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertensionMichael Newnham, Kieron South, Marta Bleda, et al.
Respiration; International Review of Thoracic Diseases|June 12, 2026
Real-world Sotatercept Eligibility: Analysis from the FOCUS-PAH RegistryGiulio Savonitto, Giovanni Santi, Matteo Pagnesi, et al.
The European Respiratory Journal|December 23, 2018
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertensionEkkehard Grünig, Christina Eichstaedt, Joan-Albert Barberà, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2020
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J Rhodes, Pablo Otero-Núñez, John Wharton, et al.
ERJ Open Research|February 23, 2023
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19Luke Daines, Bang Zheng, Omer Elneima, et al.
Pageof 12